Sensex loses 360 points, Nifty ends at 10,350; RIL leads the plunge, Lupin, Cipla worst losers Posted on 7th November 2017 |
.jpg) |
| Sensex and Nifty lost up to 1%, ended down after the slump in the shares of Reliance Industries, Lupin and State Bank of India. However, domestic stock markets hit the fresh record highs in the early afternoon trade. The sell-off in the stocks of heavyweight companies such as Lupin, Cipla, Bharti Airtel, State Bank of India, RIL, Tata Motors and Sun Pharma led the indices into the red. Indian stock markets are weighing on the mixed sentiments about Q2 corporate earnings. BSE Sensex lost 360.43 points or 1.07% to finish at 33,370.76 points while NSE Nifty washed off 101.65 points or 0.97% to end at 10,350.15 points. Shares of the Mumbai-based pharmaceutical company Lupin dived nearly 18% to hit the 52-week low on Tuesday after the US drug regulator issued warnings for company’s two sites. USFDA issued a combined warning letter for company’s Goa and Indore (Pithampur Unit II) sites. The stock of the drugmaker was the worst loser, tanked as much as 17.73% to hit the 52-week low of Rs 851.2 before closing down 16.84% 860.5 on BSE. “We are deeply disappointed to receive this outcome. While there will be no disruption of existing product supplies from either of these locations, there will likely be a delay of new product approvals from these two facilities,” Lupin said in an exchange filing. Other major laggards include SBI (down 3.57%), Airtel (down 3.45%), RIL (down 2.98%) and Sun Pharma (down 2.5%) while on the other hand, Infosys, TCS, Kotak Mahindra Bank, and Wipro gained up to 2.92%. The blue-chip stocks of RIL, SBI, Lupin, HDFC, ICICI Bank, Cipla and Bharti Airtel contributed heavily to the Sensex drop. Collectively these seven stocks alone shaved off about 292 points out of the 360-point plunge in the index. The benchmark Sensex dropped as much as 389.37 points to hit the day’s low of 33,341.82 whereas the broader Nifty lost 111 points to mark the day’s low at 10,340.8. Shares of Cipla tumbled more than 8% on Tuesday even after the pharmaceutical company reported a rise of 19% in the consolidated net profit. India’s second-largest drugmaker Cipla’s consolidated net profit was at Rs 423 crore for the July-September quarter for the financial year 2017-2018. The company had reported a net profit of Rs 354 crore in the corresponding period of FY 2016-2017. Following the results announcement, the stock of Cipla crashed as much as 8.24% to hit the day’s low of Rs 601.4 before closing down 7.18% at Rs 608.35 on BSE. |
|
|
|
|
Bharti Airtel defers Q2 results till Nov 14 over ambiguity on AGR verdict Posted on 29th October 2019 |
.jpg) |
Bharti Airtel said on Tuesday it has postponed its second-quarter earnings report to mid-November, as the wireless operator sought clarity on the court ruling asking telecom firms to cough up overdue payments to the government.
Shares of the company, which was expected to release its quarterly numbers later in the day, dropped 3.3 per cent in early trade. |
|
|
Rupee slips 8 paise vs US dollar in early trade amid drop in oil prices Posted on 7th October 2019 |
.jpg) |
The rupee on Monday opened eight paise lower at 70.96 against the US dollar amid drop in crude oil prices and rise in Asian equities. The domestic unit on Friday closed almost flat at 70.88 against after the Reserve Bank of India (RBI) in a widely expected move cut key interest rates by 0.25 percentage point. On a weekly basis, the local unit slumped by 32 paise. |
|
|
LIC pips private insurers in first-year premium growth during April-August Posted on 13th September 2019 |
.jpg) |
In the first five months of the current financial year, first-year premiums of life insurance companies grew by 39.84% (year-on-year) at Rs 1.05 lakh crore as compared to Rs 75,588.35 crore in April-August of 2018-19. Life Insurance Corporation of India (LIC) continued to grow at a faster pace compared to private insurance players, shows the data from the Insurance Regulatory and Development Authority of India (Irdai). |
|
|
Apollo Hospitals rules out further stake sale Posted on 13th September 2019 |
.jpg) |
Apollo Hospitals Enterprise (AHEL) has ruled out further dilution of promoters’ stake in the company. The company also said its Rs 1,337-crore stake sale of Apollo Munich Health Insurance with mortgage major HDFC will be concluded by October. Following these stake sales, the promoters’ pledged position will come down from a high of 76% to 54% by October and eventually to 20% by November or December, company sources said here. |
|
|
World trusts India on Kashmir, not us: Pakistan minister Ijaz Ahmed Shah Posted on 13th September 2019 |
.jpg) |
In a major embarrassment for Pakistan and its Prime Minister Imran Khan, the country's Interior Minister Ijaz Ahmed Shah, a retired brigadier, said the international community didn't believe Pakistan's narrative on Kashmir; instead it is India whose version is trusted. |
|
|
|
|
| Be the first person to write a business review for Sensex loses 360 points, Nifty ends at 10,350; RIL leads the plunge, Lupin, Cipla worst losers |
|
|
|